SLC3A2 and non-small cell lung carcinoma: The relationship between PTPRJ and CD98hc is interesting also from a clinical point of view since non-small cell lung cancer (NSCLC) patients who experienced the longest survival presented lower expression of CD98hc and higher expression of PTPRJ genes compared to patients with poor outcome (www.canevolve.org).